[DOCUMENT TITLE]
Test Bank For Rodak's Hematology: Clinical Principles
And Applications 7th Edition By Elaine M. Keohane
Latest Update 2025/2026 A+
Page 1 of 270
, [DOCUMENT TITLE]
Table Of Contents
part i: introduction to hematology
1. an overview of clinical laboratory hematology
2. patient safety in hematology and hemostasis
3. quality assurance in hematology and hemostasis testing
part ii: blood cell production, structure, and function
4. cell structure and function
5. hematopoiesis
6. erythrocyte production and destruction
7. erythrocyte metabolism and membrane structure and function
8. hemoglobin metabolism
9. iron kinetics and laboratory assessment
10. leukocyte development, kinetics, and functions
11. platelet production, structure, and function
part iii: laboratory evaluation of blood cells
12. manual, semiautomated, and point-of-care testing in hematology
13. automated blood cell analysis
14. examination of the peripheral blood film and correlation with the complete blood count
15. bone marrow examination
part iv: erythrocyte disorders
16. anemias: red blood cell morphology and approach to diagnosis
17. disorders of iron kinetics and heme metabolism
18. anemias caused by defects of dna metabolism
19. bone marrow failure
20. introduction to increased destruction of erythrocytes
21. intrinsic defects leading to increased erythrocyte destruction
22. extrinsic defects leading to increased erythrocyte destruction – nonimmune causes
23. extrinsic defects leading to increased erythrocyte destruction – immune causes
24. hemoglobinopathies (structural defects in hemoglobin)
25. thalassemias
part v: leukocyte disorders
26. nonmalignant leukocyte disorders
Page 2 of 270
, [DOCUMENT TITLE]
27. introduction to hematologic neoplasms
28. flow cytometric analysis in hematologic disorders
29. molecular diagnostics in hematopathology
30. cytogenetics
31. acute leukemias
32. myeloproliferative neoplasms
33. myelodysplastic neoplasms
34. mature lymphoid neoplasms
part vi: hemostasis and thrombosis
35. normal hemostasis
36. hemorrhagic disorders and laboratory assessment
37. qualitative disorders of platelets and vasculature
38. quantitative disorders of platelets: thrombocytopenia and thrombocytosis
39. thrombotic disorders and laboratory assessment
40. antithrombotic therapies and laboratory assessment
41. laboratory evaluation of hemostasis
42. hemostasis and coagulation instrumentation
part vii: hematology and hemostasis in selected populations
43. hematology and hemostasis in the pediatric, pregnant, geriatric, and transgender populations
e1. safety in the hematology laboratory
e2. blood specimen collection
e3. care and use of the microscope
e4. body fluid analysis in the hematology laboratory
Page 3 of 270
, [DOCUMENT TITLE]
1. chapter 01-01
hematology is the study of:
*a. ans:. blood cells.
b. serum electrolytes.
c. plasma hormone levels.
d. bacteria in the blood.
general feedback:
hematology is the study of blood cells*red blood cells, white blood cells, and platelets.
plasma and serum electrolytes and hormone levels are evaluated in various subdivisions of clinical chemistry, and bacteria
are evaluated in clinical microbiology.
2. chapter 01-02
the morphology of blood cells isimportant to evaluate:
a. every time a complete blood count (cbc)is requested on a patient.
b. when an instrument-generated flag isobtained.
*c. ans: when a profiling instrument result is abnormal.
d. when the white count is elevated.
general feedback:
every laboratory must determine*based on its instrumentation, needs of the clinician and other parameter
flags that alert the medical laboratory scientist to the necessity for further evaluation* when it is necessary to evaluate cell
morphology. many instrument-generated flags, although useful, may not require review. if an automated cbcdoes not suggest
the need, no reason exists to evaluate the blood film, even if the white count is elevated.
3. chapter 01-03
who is ultimately responsible for determining the specimen integrity before analysis?
*a. ans:. medical laboratory professional
b. nursing staff
c. phlebotomist
d. specimen-processing personnel
general feedback:
the medical laboratory scientist is responsible for ensuring the integrity of a specimen before analysis. only
he or she can judge whether the specimen is acceptable so that valid results can beobtained. acceptable criteria include such
things as type of specimen for the test ordered (e.g., blood, serum, urine); appropriate additive present (if needed) and amount
of specimen relative to the additive; time interval since obtained; and presence or absence of hemolysis, lipemia, and other
similar conditions. none of the other personnel named have the education and understanding to fully make that judgment.
2
Page 4 of 270
Test Bank For Rodak's Hematology: Clinical Principles
And Applications 7th Edition By Elaine M. Keohane
Latest Update 2025/2026 A+
Page 1 of 270
, [DOCUMENT TITLE]
Table Of Contents
part i: introduction to hematology
1. an overview of clinical laboratory hematology
2. patient safety in hematology and hemostasis
3. quality assurance in hematology and hemostasis testing
part ii: blood cell production, structure, and function
4. cell structure and function
5. hematopoiesis
6. erythrocyte production and destruction
7. erythrocyte metabolism and membrane structure and function
8. hemoglobin metabolism
9. iron kinetics and laboratory assessment
10. leukocyte development, kinetics, and functions
11. platelet production, structure, and function
part iii: laboratory evaluation of blood cells
12. manual, semiautomated, and point-of-care testing in hematology
13. automated blood cell analysis
14. examination of the peripheral blood film and correlation with the complete blood count
15. bone marrow examination
part iv: erythrocyte disorders
16. anemias: red blood cell morphology and approach to diagnosis
17. disorders of iron kinetics and heme metabolism
18. anemias caused by defects of dna metabolism
19. bone marrow failure
20. introduction to increased destruction of erythrocytes
21. intrinsic defects leading to increased erythrocyte destruction
22. extrinsic defects leading to increased erythrocyte destruction – nonimmune causes
23. extrinsic defects leading to increased erythrocyte destruction – immune causes
24. hemoglobinopathies (structural defects in hemoglobin)
25. thalassemias
part v: leukocyte disorders
26. nonmalignant leukocyte disorders
Page 2 of 270
, [DOCUMENT TITLE]
27. introduction to hematologic neoplasms
28. flow cytometric analysis in hematologic disorders
29. molecular diagnostics in hematopathology
30. cytogenetics
31. acute leukemias
32. myeloproliferative neoplasms
33. myelodysplastic neoplasms
34. mature lymphoid neoplasms
part vi: hemostasis and thrombosis
35. normal hemostasis
36. hemorrhagic disorders and laboratory assessment
37. qualitative disorders of platelets and vasculature
38. quantitative disorders of platelets: thrombocytopenia and thrombocytosis
39. thrombotic disorders and laboratory assessment
40. antithrombotic therapies and laboratory assessment
41. laboratory evaluation of hemostasis
42. hemostasis and coagulation instrumentation
part vii: hematology and hemostasis in selected populations
43. hematology and hemostasis in the pediatric, pregnant, geriatric, and transgender populations
e1. safety in the hematology laboratory
e2. blood specimen collection
e3. care and use of the microscope
e4. body fluid analysis in the hematology laboratory
Page 3 of 270
, [DOCUMENT TITLE]
1. chapter 01-01
hematology is the study of:
*a. ans:. blood cells.
b. serum electrolytes.
c. plasma hormone levels.
d. bacteria in the blood.
general feedback:
hematology is the study of blood cells*red blood cells, white blood cells, and platelets.
plasma and serum electrolytes and hormone levels are evaluated in various subdivisions of clinical chemistry, and bacteria
are evaluated in clinical microbiology.
2. chapter 01-02
the morphology of blood cells isimportant to evaluate:
a. every time a complete blood count (cbc)is requested on a patient.
b. when an instrument-generated flag isobtained.
*c. ans: when a profiling instrument result is abnormal.
d. when the white count is elevated.
general feedback:
every laboratory must determine*based on its instrumentation, needs of the clinician and other parameter
flags that alert the medical laboratory scientist to the necessity for further evaluation* when it is necessary to evaluate cell
morphology. many instrument-generated flags, although useful, may not require review. if an automated cbcdoes not suggest
the need, no reason exists to evaluate the blood film, even if the white count is elevated.
3. chapter 01-03
who is ultimately responsible for determining the specimen integrity before analysis?
*a. ans:. medical laboratory professional
b. nursing staff
c. phlebotomist
d. specimen-processing personnel
general feedback:
the medical laboratory scientist is responsible for ensuring the integrity of a specimen before analysis. only
he or she can judge whether the specimen is acceptable so that valid results can beobtained. acceptable criteria include such
things as type of specimen for the test ordered (e.g., blood, serum, urine); appropriate additive present (if needed) and amount
of specimen relative to the additive; time interval since obtained; and presence or absence of hemolysis, lipemia, and other
similar conditions. none of the other personnel named have the education and understanding to fully make that judgment.
2
Page 4 of 270
